Saturday 17 October 2026
Export MBX’s income statement to Excel — free account
MBX Biosciences, Inc.
In the quarter to June 2026, EPS fell 34.5% and free cash flow fell 29.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
49.61
1.10
−2.17%
Follow MBX
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
12.89 | 21.26 | 24.19 | 24.62 |
Net Debt/EBITDA |
1.69 | 2.29 | 3.86 | 3.82 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.88 | 0.98 | 0.88 | 0.92 |
Capex/Depreciation |
(7.87) | (0.82) | (3.58) | (7.78) |
Interest Coverage |
(67.28) | — | — | — |
| 0.00% | 56.60% | (66.95%) | (27.76%) | |
| 0.00% | (50.38%) | (35.11%) | (26.61%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(63.28%) | (40.71%) | (24.06%) | (23.58%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(35.33) | (31.51) | (5.22) | (2.24) |
Cash per Share |
63.66 | 79.17 | 24.63 | 10.24 |
Shareholders Equity per Share |
(63.88) | (71.12) | 24.19 | 10.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(63.88) | (71.12) | 24.19 | 10.11 |
Free Cash Flow |
(23.56) | (32.11) | (55.55) | (81.88) |
Working Capital |
40.78 | 79.54 | 256.24 | 366.04 |
Capital Expenditures |
(0.44) | (0.13) | (0.87) | (1.93) |
Net Current Asset Value |
(43.49) | (73.18) | 256.19 | 365.62 |
| Other line items | ||||
Quick Ratio |
12.38 | 20.55 | 23.72 | 24.12 |
Depreciation/Fixed assets |
0.11 | 0.36 | 0.23 | 0.09 |
Cash ROIC |
16,363.19% | (391.17%) | (10.69%) | (11.02%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(34.67) | (31.38) | (5.14) | (2.19) |
Capex per Share |
(0.66) | (0.13) | (0.08) | (0.05) |
Average Payables |
— | 1.18 | 3.36 | 4.16 |
Average Assets |
— | 64.64 | 176.36 | 326.84 |
Average Common Equity |
— | (57.54) | 92.49 | 313.33 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates